tradingkey.logo
tradingkey.logo
Search

Alpha Teknova Inc

TKNO
Add to Watchlist
3.510USD
-0.210-5.65%
Close 05/15, 16:00ETQuotes delayed by 15 min
188.19MMarket Cap
LossP/E TTM

Alpha Teknova Inc

3.510
-0.210-5.65%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Alpha Teknova Inc

Currency: USD Updated: 2026-05-15

Key Insights

Alpha Teknova Inc's fundamentals are relatively healthy, with industry-average ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 88 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 9.00.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Alpha Teknova Inc's Score

Industry at a Glance

Industry Ranking
88 / 206
Overall Ranking
209 / 4482
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Alpha Teknova Inc Highlights

StrengthsRisks
Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary product categories, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. It supports customers spanning the life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and others, with catalog and custom, made-to-order products.
Growing
The company is in a growing phase, with the latest annual income totaling USD 40.52M.
Fairly Valued
The company’s latest PE is -10.94, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 45.71M shares, decreasing 3.80% quarter-over-quarter.
Held by Chuck Royce
Star Investor Chuck Royce holds 1.07M shares of this stock.

Analyst Rating

Based on 6 analysts
Buy
Current Rating
9.000
Target Price
+141.94%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-05-15

The current financial score of Alpha Teknova Inc is 6.11, ranking 168 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 11.08M, representing a year-over-year increase of 13.09%, while its net profit experienced a year-over-year increase of 1.94%.

Score

Industry at a Glance

Previous score
6.11
Change
0

Financials

6.31

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

6.45

Operational Efficiency

6.61

Growth Potential

4.07

Shareholder Returns

7.11

Alpha Teknova Inc's Company Valuation

Currency: USD Updated: 2026-05-15

The current valuation score of Alpha Teknova Inc is 6.86, ranking 140 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -10.94, which is -91.75% below the recent high of -0.90 and -55.87% above the recent low of -17.06.

Score

Industry at a Glance

Previous score
6.86
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 88/206
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-05-15

The current earnings forecast score of Alpha Teknova Inc is 8.00, ranking 66 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 8.00, with a high of 12.00 and a low of 7.00.

Score

Industry at a Glance

Previous score
8.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 6 analysts
Buy
Current Rating
9.000
Target Price
+141.94%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

116
Total
6
Median
9
Average
Company name
Ratings
Analysts
Alpha Teknova Inc
TKNO
6
Medtronic PLC
MDT
33
Stryker Corp
SYK
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
31
Dexcom Inc
DXCM
31
1
2
3
...
23

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-05-15

The current price momentum score of Alpha Teknova Inc is 7.34, ranking 47 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 4.40 and the support level at 2.69, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
8.87
Change
-1.53

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(3)
Neutral(3)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.015
Neutral
RSI(14)
52.264
Neutral
STOCH(KDJ)(9,3,3)
27.339
Sell
ATR(14)
0.325
High Vlolatility
CCI(14)
-40.857
Neutral
Williams %R
68.799
Sell
TRIX(12,20)
1.236
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(3)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MA5
3.788
Sell
MA10
3.774
Sell
MA20
3.490
Buy
MA50
3.082
Buy
MA100
3.047
Buy
MA200
3.938
Sell

Institutional Confidence

Currency: USD Updated: 2026-05-15

Score

Industry at a Glance

Previous score
7.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Telegraph Hill Partners
37.72M
--
Davis (Ted)
1.89M
--
Roubaix Capital, LLC
998.53K
+19.75%
Davis (Irene)
1.69M
--
Royce Investment Partners
Star Investors
293.58K
--
Balyasny Asset Management LP
987.20K
-0.00%
Mackowski J Matthew
820.81K
--
BlackRock Institutional Trust Company, N.A.
633.34K
+4.16%
UBS Financial Services, Inc.
734.89K
-51.00%
1
2

Risk Assessment

Currency: USD Updated: 2026-05-15

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Alpha Teknova Inc is 2.95, ranking 137 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.48. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Alpha Teknova Inc’s latest ESG disclosure is at an average level in the Healthcare Equipment & Supplies industry, showing no material impact on overall risk.

Score

Industry at a Glance

Previous score
2.95
Change
0
Beta vs S&P 500 index
0.46
VaR
+8.66%
240-Day Maximum Drawdown
+68.76%
240-Day Volatility
+93.12%

Return

Best Daily Return
60 days
+21.70%
120 days
+21.70%
5 years
+42.22%
Worst Daily Return
60 days
-9.57%
120 days
-14.79%
5 years
-21.09%
Sharpe Ratio
60 days
+2.92
120 days
-0.21
5 years
+0.05

Risk Assessment

Maximum Drawdown
240 days
+68.76%
3 years
+79.61%
5 years
+95.63%
Return-to-Drawdown Ratio
240 days
-0.56
3 years
+0.14
5 years
-0.17
Skewness
240 days
+0.84
3 years
+1.28
5 years
+1.08

Volatility

Realised Volatility
240 days
+93.12%
5 years
+118.45%
Standardised True Range
240 days
+9.39%
5 years
+18.51%
Downside Risk-Adjusted Return
120 days
-38.46%
240 days
-38.46%
Maximum Daily Upside Volatility
60 days
+83.15%
Maximum Daily Downside Volatility
60 days
+60.82%

Liquidity

Average Turnover Rate
60 days
+0.24%
120 days
+0.34%
5 years
--
Turnover Deviation
20 days
-74.05%
60 days
-63.61%
120 days
-47.60%

Peer Comparison

Healthcare Equipment & Supplies
Alpha Teknova Inc
Alpha Teknova Inc
TKNO
6.62 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
Lantheus Holdings Inc
LNTH
8.68 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
Anika Therapeutics Inc
ANIK
8.58 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LivaNova PLC
LIVN
8.37 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc
TMO
8.35 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bruker Corp
Bruker Corp
BRKR
8.23 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI